期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

地高辛与大环内酯类抗生素相互作用的研究进展 被引量：5

暂未订购
导出
摘要 20世纪后期，特别是90年代，随着对心力衰竭（心衰）发生、发展机制的研究和认识的不断深入．心衰的治疗概念发生了根本性转变。过去一向认为，慢性心衰只是心脏病的不可逆终末期过程：如今已有证据表明，慢性衰竭心脏结构功能的内源性缺陷，可以通过干预达到真正的生物学改善。虽然目前治疗心衰的药物种类大大增加，但是传统应用的洋地黄类至今在临床上仍广泛应用。地高辛起效快．作用时间较短，其浓度又易于测定，应用最广泛，
作者 于慧斌 孙成春
机构地区 辽宁医学院 济南军区总医院药剂科
出处 《实用医药杂志》 2009年第6期66-68,共3页 Practical Journal of Medicine & Pharmacy
关键词 地高辛 大环内酯类抗生素
分类号 R969.2 [医药卫生—药理学]
  • 相关文献

参考文献23

  • 1崔红玉.地高辛与门冬氨酸阿奇霉素联用致心律失常1例[J].中国误诊学杂志,2006,6(16):3270-3271. 被引量：9
  • 2Morton MR, Cooper JW. Erythromycin-induced digoxin toxicity. DICP, 1989,23(9):668.
  • 3Corallo CE, Rogers IR. Roxithromycin-induced digoxin toxicity. Med J Aust, 1996,165(8):433.
  • 4Nenciu LM, Laberge P, Thirion DJ. Telithromycin-induced digoxin toxicity and electrocardiographic changes. Pharmacotherapy, 2006,26(6):872.
  • 5Cambonie G, Sabatier E, Guillaumont S, et al. Digoxin-Josamycin: a dangerous drug interaction in children. Arch Pediatr, 2006, 13(8):1118.
  • 6Nawarskas JJ, McCarthy DM, Spinier SA. Digoxin toxicity secondary to clarithromycin therapy. Ann Pharmacother, 1997,31(7- 8):864.
  • 7Laberge P, Martineau P. Clarithromycin-induced digoxin intoxication. Ann Pharmacother, 1997,31(9):999.
  • 8Guerriero SE, Ehrenpreis E, Gallagher KL. Two cases of clarithromycin-induced digoxin toxicity. Pharmacotherapy, 1997,17(5): 1035.
  • 9Nordt SP, Williams SR, Manoguerra AS, et al. Clarithromycin induced digoxin toxicity. J Accid Emerg Med, 1998,15(3):194.
  • 10Xu H, Rashkow A. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature. Conn Med, 2001, 65(9):527.

二级参考文献22

  • 1Choi CH.ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal[J].Cancer Cell International,2005,5:30
  • 2Arora A,Seth K,Shukla Y.Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver[J].Carcinogenesis,2004,25(6):941-949
  • 3Lin JH,Yamazaki M.Clinical relevance of P-glycoprotein in drug therapy[J].Drug Metab Rev,2003,35 (4):417-54
  • 4BARRANCO.SAMC.Method and kit for testing tumors for drug sensitivity[P].World(PTC) patent,WO9325705,1993-12-23
  • 5Karen VC,Ross AD Mary WD.Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells[J].Biochemical Pharmacology,2001,62(4):417-424
  • 6Tsuruo T,Tida H,Tsukago S,et al.Increased accumulation of vincristine and adriamycin in drugresistance P388 tumour cells following incubation with calcium antagonist and calmodulin inhibitors[J].Cancer Res,1982,42 (11):4730-4733
  • 7Cowie FJ,Pinkerton CR,Phillips M,et al.Continuousin fusion verapamil with etoposide in relapsed or resistant paediatric cancers[J].BrI Cancer,1995,71 (4):877-881
  • 8Berti E,Carrara M,Ragazzi E,et al.A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line[J].Int J Oncol,1999,15 (1):155-160
  • 9Wainer IW.Stereoisomers in clinical oncology:why it is imPortant to know what the right and left hands are doing[J].Ann Oncol,1993,4(2):7-13
  • 10Bissett D,Kerr DJ,Cassidy J,et al.Phase I and pharmacokinetic study of D-verapamil and doxorubicin[J].Br J Cancer,1991,64(6):1168-1171

共引文献9

同被引文献68

引证文献5

二级引证文献28

实用医药杂志
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部